| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3410214 | The Lancet Infectious Diseases | 2015 | 4 Pages |
Abstract
SummaryThe epidemic of Ebola virus disease has spread at an alarming rate despite containment efforts. As a result, unprecedented large-scale international response efforts have been made in an attempt to gain control of the outbreak and reduce transmission. Several international consortia have been formed in a remarkable worldwide collaborative effort to expedite trials of two candidate Ebola virus vaccines: cAd3-EBOZ and rVSV-EBOV. In parallel, both vaccines are being manufactured in large amounts to enable future rapid deployment for management of the crisis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Claire M Tully, Teresa Lambe, Sarah C Gilbert, Adrian V S Hill,